- Home
- NPV vs CATX Comparison
NPV vs CATX Comparison
Compare NPV & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- CATX
- Stock Information
- Founded
- NPV 1993
- CATX 1983
- Country
- NPV United States
- CATX United States
- Employees
- NPV N/A
- CATX N/A
- Industry
- NPV Investment Managers
- CATX Medical/Dental Instruments
- Sector
- NPV Finance
- CATX Health Care
- Exchange
- NPV Nasdaq
- CATX Nasdaq
- Market Cap
- NPV 211.4M
- CATX 239.0M
- IPO Year
- NPV N/A
- CATX N/A
- Fundamental
- Price
- NPV $11.47
- CATX $2.73
- Analyst Decision
- NPV
- CATX Strong Buy
- Analyst Count
- NPV 0
- CATX 10
- Target Price
- NPV N/A
- CATX $12.30
- AVG Volume (30 Days)
- NPV 38.9K
- CATX 1.7M
- Earning Date
- NPV 01-01-0001
- CATX 11-10-2025
- Dividend Yield
- NPV 3.90%
- CATX N/A
- EPS Growth
- NPV N/A
- CATX N/A
- EPS
- NPV N/A
- CATX N/A
- Revenue
- NPV N/A
- CATX $1,235,000.00
- Revenue This Year
- NPV N/A
- CATX N/A
- Revenue Next Year
- NPV N/A
- CATX N/A
- P/E Ratio
- NPV N/A
- CATX N/A
- Revenue Growth
- NPV N/A
- CATX N/A
- 52 Week Low
- NPV $8.92
- CATX $1.60
- 52 Week High
- NPV $11.55
- CATX $12.90
- Technical
- Relative Strength Index (RSI)
- NPV 55.88
- CATX 36.83
- Support Level
- NPV $11.42
- CATX $2.83
- Resistance Level
- NPV $11.57
- CATX $3.15
- Average True Range (ATR)
- NPV 0.10
- CATX 0.46
- MACD
- NPV -0.00
- CATX -0.16
- Stochastic Oscillator
- NPV 76.31
- CATX 0.63
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.